Pim van der Harst

73.6k total citations · 5 hit papers
385 papers, 12.5k citations indexed

About

Pim van der Harst is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Pim van der Harst has authored 385 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Cardiology and Cardiovascular Medicine, 81 papers in Radiology, Nuclear Medicine and Imaging and 72 papers in Surgery. Recurrent topics in Pim van der Harst's work include Cardiac Imaging and Diagnostics (74 papers), Cardiovascular Function and Risk Factors (56 papers) and Acute Myocardial Infarction Research (45 papers). Pim van der Harst is often cited by papers focused on Cardiac Imaging and Diagnostics (74 papers), Cardiovascular Function and Risk Factors (56 papers) and Acute Myocardial Infarction Research (45 papers). Pim van der Harst collaborates with scholars based in Netherlands, United Kingdom and United States. Pim van der Harst's co-authors include Niek Verweij, Wiek H. van Gilst, Dirk J. van Veldhuisen, Rudolf A. de Boer, Hans L. Hillege, Adriaan A. Voors, M. Abdullah Said, Erik Lipšic, Stephan J. L. Bakker and Hisko Oeseburg and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Medicine.

In The Last Decade

Pim van der Harst

366 papers receiving 12.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease

2017 653 citations Pim van der Harst et al. profile →
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND

2013 423 citations Rudolf A. de Boer, Pim van der Harst et al. profile →
Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study

2018 399 citations Pim van der Harst et al. profile →
A Genotype-Guided Strategy for Oral P2Y ₁₂ Inhibitors in Primary PCI

2019 378 citations Daniel M.F. Claassens, Gerrit J.A. Vos et al. New England Journal of Medicine profile →
Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

2022 99 citations Pim van der Harst et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pim van der Harst Netherlands	54	5.4k	2.6k	2.1k	1.8k	1.4k	385	12.5k
Nilesh J. Samani United Kingdom	55	4.5k 0.8×	3.2k 1.2×	3.1k 1.5×	1.5k 0.8×	1.0k 0.7×	328	12.3k
Julian Halcox United Kingdom	43	5.5k 1.0×	3.4k 1.3×	2.0k 1.0×	2.9k 1.6×	1.5k 1.1×	147	13.7k
Peter Riis Hansen Denmark	62	5.8k 1.1×	1.4k 0.5×	1.3k 0.6×	2.1k 1.2×	2.5k 1.8×	334	14.1k
Vera Regitz‐Zagrosek Germany	62	7.1k 1.3×	3.1k 1.2×	1.3k 0.6×	2.0k 1.1×	559 0.4×	298	14.7k
Susan Cheng United States	66	8.1k 1.5×	4.4k 1.7×	3.6k 1.7×	1.8k 1.0×	920 0.7×	346	18.0k
Erik Ingelsson Sweden	63	3.3k 0.6×	2.9k 1.1×	2.0k 1.0×	1.5k 0.8×	743 0.5×	209	12.8k
Danilo Fliser Germany	75	4.3k 0.8×	4.0k 1.6×	2.3k 1.1×	2.7k 1.5×	1.9k 1.4×	301	18.6k
Tanja Zeller Germany	48	4.0k 0.8×	2.7k 1.0×	675 0.3×	1.4k 0.8×	820 0.6×	351	9.8k
Ron C. Hoogeveen United States	54	4.2k 0.8×	1.6k 0.6×	1.7k 0.8×	3.1k 1.7×	1.1k 0.8×	252	11.5k
Yoshihiro Miyamoto Japan	50	5.1k 0.9×	2.1k 0.8×	2.2k 1.0×	1.9k 1.1×	471 0.3×	454	10.9k

Countries citing papers authored by Pim van der Harst

Since Specialization

Citations

This map shows the geographic impact of Pim van der Harst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pim van der Harst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pim van der Harst more than expected).

Fields of papers citing papers by Pim van der Harst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pim van der Harst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pim van der Harst. The network helps show where Pim van der Harst may publish in the future.

Co-authorship network of co-authors of Pim van der Harst

This figure shows the co-authorship network connecting the top 25 collaborators of Pim van der Harst. A scholar is included among the top collaborators of Pim van der Harst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pim van der Harst. Pim van der Harst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guglielmo, Marco, Maarten J. Cramer, Pim van der Harst, et al.. (2025). Optimizing CRT Lead Placement Accuracy With CMR-Guided On-Screen Targeting. JACC. Clinical electrophysiology. 11(6). 1293–1305.

Asatryan, Babken, Alessio Gasperetti, Maarten J. Cramer, et al.. (2025). Family Screening in Relatives at Risk for Plakophilin-2–Associated Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation. 152(5). 313–326.

Koning, Harry J. de, Marleen Vonder, Jan W. Gratama, et al.. (2024). Short-term impact of cardiovascular screening by traditional risk assessment or coronary artery calcium score on health-related quality of life: the ROBINSCA trial. European Heart Journal Open. 4(5). oeae080–oeae080.

Horst, Iwan C.C. van der, et al.. (2024). Left atrial strain predicts long-term heart failure outcomes after ST-elevation myocardial infarction. International Journal of Cardiology. 422. 132931–132931. 1 indexed citations

Jukema, Ruurt, Sharon Remmelzwaal, Pieter G. Raijmakers, et al.. (2024). Diagnostic performance of CCTA and CTP imaging for clinically suspected in-stent restenosis: A meta-analysis. Journal of cardiovascular computed tomography. 19(2). 183–190.

Pundziūtė, Gabija, Carlijn M. van der Aalst, Jan W. Gratama, et al.. (2022). Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial. American Heart Journal. 246. 166–177. 4 indexed citations

Voskuil, Michiel, Mèra Stein, Peter Frambach, et al.. (2021). 3-Year Clinical Outcomes After Implantation of Permanent-Polymer Versus Polymer-Free Stent. JACC: Cardiovascular Interventions. 14(22). 2477–2486. 10 indexed citations

Börschel, Christin S., Bastiaan Geelhoed, Teemu Niiranen, et al.. (2020). Risk prediction of atrial fibrillation in the community combining biomarkers and genetics. EP Europace. 23(5). 674–681. 16 indexed citations

Suthahar, Navin, Laura M G Meems, Dirk J. van Veldhuisen, et al.. (2020). High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men. Mayo Clinic Proceedings. 95(6). 1158–1168. 11 indexed citations

10.

Wijst, Monique G.P. van der, Hilde E. Groot, Gosia Trynka, et al.. (2020). The single-cell eQTLGen consortium. eLife. 9. 116 indexed citations

11.

Assa, Solmaz, Dirk J. van Veldhuisen, Andreas Pasch, et al.. (2020). Safety and Tolerability of Sodium Thiosulfate in Patients with an Acute Coronary Syndrome Undergoing Coronary Angiography: A Dose-Escalation Safety Pilot Study (SAFE-ACS). Journal of Interventional Cardiology. 2020. 1–8. 21 indexed citations

12.

Claassens, Daniel M.F., Gerrit J.A. Vos, Thomas O. Bergmeijer, et al.. (2019). A Genotype-Guided Strategy for Oral P2Y ₁₂ Inhibitors in Primary PCI. New England Journal of Medicine. 381(17). 1621–1631. 378 indexed citations breakdown →

13.

Hendriks, Tom, et al.. (2018). Left ventricular restoration devices post myocardial infarction. Heart Failure Reviews. 23(6). 871–883. 12 indexed citations

14.

Tromp, Jasper, B. Daan Westenbrink, Wouter Ouwerkerk, et al.. (2018). Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction. Journal of the American College of Cardiology. 72(10). 1081–1090. 208 indexed citations

15.

Stillman, Arthur E., Matthijs Oudkerk, David A. Bluemke, et al.. (2018). Imaging the myocardial ischemic cascade. International journal of cardiac imaging. 34(8). 1249–1263. 30 indexed citations

16.

Delewi, Ronak, Chris P. H. Lexis, Martijn W. Smulders, et al.. (2016). The relationship between terminal QRS distortion on initial ECG and final infarct size at 4 months in conventional ST- segment elevation myocardial infarct patients. Journal of Electrocardiology. 49(3). 292–299. 6 indexed citations

17.

Gorter, Thomas M., Chris P. H. Lexis, Yoran M. Hummel, et al.. (2016). Right Ventricular Function After Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the Glycometabolic Intervention as Adjunct to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction III Trial). The American Journal of Cardiology. 118(3). 338–344. 23 indexed citations

18.

Tomaszewski, Maciej, Fadi J. Charchar, Christopher P. Nelson, et al.. (2011). Pathway Analysis Shows Association between FGFBP1 and Hypertension. Journal of the American Society of Nephrology. 22(5). 947–955. 22 indexed citations

19.

Li, Jiang, Inge Vreeswijk‐Baudoin, Pim van der Harst, et al.. (2010). Activation of Liver X Receptors with T0901317 Attenuates Cardiac Hypertrophy in vivo. European Journal of Heart Failure. 12(10). 1042–1050. 33 indexed citations

20.

Oeseburg, Hisko, Dilek Iusuf, Wiek H. van Gilst, et al.. (2008). Bradykinin protects against endothelial cell senescence. Data Archiving and Networked Services (DANS). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact